Text Size
369 studies found for:    nasopharyngeal cancer | "Nasopharyngeal Carcinoma"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
nasopharyngeal cancer | "Nasopharyngeal Carcinoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Suspended Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
Conditions: Stage I Lymphoepithelioma of the Nasopharynx;   Stage I Squamous Cell Carcinoma of the Nasopharynx;   Stage II Lymphoepithelioma of the Nasopharynx;   Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx
Interventions: Drug: amifostine trihydrate;   Drug: fluorouracil;   Drug: cisplatin;   Other: laboratory biomarker analysis;   Radiation: radiation therapy
2 Active, not recruiting
Has Results 		Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
Conditions: Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Biological: bevacizumab;   Drug: cisplatin;   Drug: fluorouracil
3 Recruiting Phase II Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)
Conditions: Stage II Lymphoepithelioma of the Nasopharynx;   Stage II Squamous Cell Carcinoma of the Nasopharynx;   Stage III Lymphoepithelioma of the Nasopharynx;   Stage III Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx
Interventions: Drug: docetaxel;   Drug: cisplatin;   Drug: carboplatin;   Drug: fluorouracil;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
4 Recruiting Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)
Conditions: Recurrent Nasopharyngeal Carcinoma;   Metastatic Nasopharyngeal Carcinoma
Intervention: Drug: Famitinib
5 Terminated Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Cetuximab
6 Completed Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: Late-course accelerated hyperfractionated IMRT;   Drug: Concomitant cisplatin chemotherapy;   Radiation: Conventionally fractionated IMRT
7 Unknown † Positron Emission Tomography Scanning and Epstein-Barr Virus DNA Levels in the Staging and Follow-Up of Nasopharyngeal Carcinoma.
Condition: Nasopharyngeal Carcinoma
Intervention:
8 Completed Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
Conditions: Recurrent Nasopharyngeal Cancer;   Stage IV Nasopharyngeal Cancer
Interventions: Drug: bortezomib;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis
9 Recruiting GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma
Condition: Stage IV Nasopharyngeal Carcinoma
Interventions: Drug: GC chemotherapy plus CIK cells (Gemcitabine, Cisplatin, Autologous CIK cells);   Drug: GC chemotherapy (Gemcitabine, Cisplatin)
10 Recruiting Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Icotinib;   Radiation: intensity-modulated radiotherapy;   Drug: Paclitaxel and Cisplatin;   Other: Quality of life;   Genetic: Epidermal growth factor receptor status
11 Recruiting A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: neoadjuvant chemotherapy plus concurrent chemoradiotherapy
12 Recruiting A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: nedaplatin and docetaxel;   Drug: cisplatin and docetaxel
13 Not yet recruiting The Role of Concurrent Chemotherapy for Lower Risk Locally Advanced Nasopharyngeal Carcinoma(NPC) in the Era of IMRT
Condition: Nasopharyngeal Carcinoma
Interventions: Radiation: SIB-IMRT;   Drug: Cisplatin
14 Active, not recruiting Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Recurrent Lymphoepithelioma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Lymphoepithelioma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Nasopharynx
Interventions: Drug: azacitidine;   Drug: vorinostat;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Procedure: axillary lymph node biopsy
15 Recruiting SOX as Salvage Treatment in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: S-1 plus oxaliplatin
16 Recruiting Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: endostatin
17 Completed Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Biological: DNAzyme targeting EBV-LMP1 (DZ1);   Other: Saline
18 Recruiting Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Docetaxel, cisplatin and fluorouracil;   Radiation: Concurrent chemoradiotherapy
19 Active, not recruiting Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cisplatin,fluorouracil;   Drug: Cisplatin
20 Active, not recruiting Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer
Condition: Nasopharyngeal Carcinoma
Interventions: Drug: Cetuximab;   Drug: Cisplatin;   Drug: Docetaxel;   Radiation: Intensity-modulated radiotherapy
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years